Pimavanserin

(Nuplazid®)

Pimavanserin

Drug updated on 11/13/2023

Dosage FormTablet (oral; 10 mg); Capsule (oral; 34 mg)
Drug ClassAtypical antipsychotics
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • For the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.